For nearly seven decades testosterone was implicated as causing prostate cancer and escalating the growth and spread of prostate cancer. Today we have determined that men with low levels of the male sex hormone testosterone need not fear that testosterone replacement therapy will increase their risk of prostate cancer.
A recent presentation at the American Urologic Association’s annual meeting in San Diego pointed out In the study, researchers found that, as a group, men prescribed testosterone for longer than a year had no overall increase in risk of prostate cancer and, in fact, had their risk of aggressive disease reduced by 50 percent.
I still be watching for prostate cancer risk factors — such as being over the age of 40, having African-American ancestry, or having a family history of the disease. Their bottom is that men taking testosterone therapy, should not hesitate to use testosterone for fear of increasing prostate cancer risk.
The investigators point out that when used appropriately by men with low testosterone who are otherwise healthy, testosterone replacement has been shown to improve sexual function and mood. Testosterone levels drop naturally by about 1 percent per year in men past their 30s. Testosterone levels drop naturally by about 1 percent per year in men past their 30s. Replacement of testosterone is accomplished with a gel patch, injections, or the insertion of small pellets under the skin that replaces the testosterone for 4-6 months.
Overall, the study suggests that what is best for men’s health is to keep testosterone levels balanced and within a normal range. Men with testosterone levels below 350 nanograms per deciliter and symptoms should seek medical advice about whether they should consider testosterone therapy.